{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:19Z","timestamp":1772166259531,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pericytes play a crucial role in controlling inflammation and vascular functions in the central nervous system, which are disrupted in Parkinson\u2019s disease (PD). Still, there is a lack of studies on the impact of pericytes on neurodegenerative diseases, and their involvement in the pathology of PD is unclear. Our objective was to investigate the molecular and functional differences between healthy pericytes and pericytes with the\n                      <jats:italic>LRRK2<\/jats:italic>\n                      G2019S mutation, which is one of the most common mutations associated with PD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Our study employed pericyte-like cells obtained from induced pluripotent stem cells produced from PD patients with the\n                      <jats:italic>LRRK2<\/jats:italic>\n                      G2019S mutation as well as from healthy individuals. We examined the gene expression profiles of the cells and analyzed how the alterations reflect on their functionality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We have shown differences in the expression of genes related to inflammation and angiogenesis. Furthermore, we observe modified migration speed in PD pericyte-like cells as well as enhanced secretion of inflammatory mediators, such as soluble VCAM-1 and MCP-1, in these pericyte-like cells following exposure to proinflammatory stimuli.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, our findings support the notion that pericytes play a role in the inflammatory and vascular changes observed in PD. Further investigation of pericytes could provide valuable insight into understanding the pathogenesis of PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-024-00592-y","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T18:02:13Z","timestamp":1731866533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mutated LRRK2 induces a reactive phenotype and alters migration in human iPSC-derived pericyte-like cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Sanni","family":"Peltonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuuli-Maria","family":"Sonninen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna","family":"Niskanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Koistinaho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160\u00e1rka","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"1","key":"592_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primer. 2021;7(1):47.","journal-title":"Nat Rev Dis Primer"},{"key":"592_CR2","doi-asserted-by":"crossref","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. Brundin P, Langston JW, Bloem BR, editors. J Park Dis. 2018;8(s1):S3\u20138.","DOI":"10.3233\/JPD-181474"},{"key":"592_CR3","doi-asserted-by":"publisher","unstructured":"Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson\u2019s Disease. In: Harris JR, editor. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease [Internet]. Dordrecht: Springer Netherlands; 2012 [cited 2024 May 24]. pp. 389\u2013455. (Subcellular Biochemistry; vol. 65). https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-94-007-5416-4_16","DOI":"10.1007\/978-94-007-5416-4_16"},{"issue":"9","key":"592_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","volume":"16","author":"Q Rui","year":"2018","unstructured":"Rui Q, Ni H, Li D, Gao R, Chen G. The role of LRRK2 in neurodegeneration of Parkinson Disease. Curr Neuropharmacol. 2018;16(9):1348\u201357.","journal-title":"Curr Neuropharmacol"},{"key":"592_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4:19.","journal-title":"Transl Neurodegener"},{"issue":"5","key":"592_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM. Striatal blood\u2013brain barrier permeability in Parkinson\u2019s Disease. J Cereb Blood Flow Metab. 2015;35(5):747\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9157","key":"592_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","volume":"353","author":"BA Faucheux","year":"1999","unstructured":"Faucheux BA, Agid Y, Hirsch EC, Bonnet AM. Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease. Lancet. 1999;353(9157):981\u20132.","journal-title":"Lancet"},{"issue":"1","key":"592_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00702-011-0684-8","volume":"119","author":"B Desai Bradaric","year":"2012","unstructured":"Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B. Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm. 2012;119(1):59\u201371.","journal-title":"J Neural Transm"},{"issue":"7323","key":"592_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genov\u00e9 G, M\u00e4e M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood\u2013brain barrier. Nature. 2010;468(7323):557\u201361.","journal-title":"Nature"},{"issue":"7323","key":"592_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood\u2013brain barrier integrity during embryogenesis. Nature. 2010;468(7323):562\u20136.","journal-title":"Nature"},{"issue":"47","key":"592_CR11","doi-asserted-by":"publisher","first-page":"23551","DOI":"10.1073\/pnas.1913373116","volume":"116","author":"TY Kang","year":"2019","unstructured":"Kang TY, Bocci F, Jolly MK, Levine H, Onuchic JN, Levchenko A. Pericytes enable effective angiogenesis in the presence of proinflammatory signals. Proc Natl Acad Sci. 2019;116(47):23551\u201361.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"592_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2016.12.001","volume":"38","author":"J Rustenhoven","year":"2017","unstructured":"Rustenhoven J, Jansson D, Smyth LC, Dragunow M. Brain Pericytes as mediators of Neuroinflammation. Trends Pharmacol Sci. 2017;38(3):291\u2013304.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"592_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-20261-0","volume":"12","author":"TJ Stevenson","year":"2022","unstructured":"Stevenson TJ, Johnson RH, Savistchenko J, Rustenhoven J, Woolf Z, Smyth LCD, et al. Pericytes take up and degrade \u03b1-synuclein but succumb to apoptosis under cellular stress. Sci Rep. 2022;12(1):1\u201317.","journal-title":"Sci Rep"},{"key":"592_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.mvr.2019.03.005","volume":"124","author":"S Dohgu","year":"2019","unstructured":"Dohgu S, Takata F, Matsumoto J, Kimura I, Yamauchi A, Kataoka Y. Monomeric \u03b1-synuclein induces blood\u2013brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro. Microvasc Res. 2019;124:61\u20136.","journal-title":"Microvasc Res"},{"issue":"1","key":"592_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41598-020-80889-8","volume":"11","author":"O Elabi","year":"2021","unstructured":"Elabi O, Gaceb A, Carlsson R, Padel T, Soylu-Kucharz R, Cortijo I, et al. Human \u03b1-synuclein overexpression in a mouse model of Parkinson\u2019s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation. Sci Rep. 2021;11(1):1120.","journal-title":"Sci Rep"},{"issue":"1","key":"592_CR16","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/npjparkd.2016.9","volume":"2","author":"S Holmqvist","year":"2016","unstructured":"Holmqvist S, Lehtonen \u0160, Chumarina M, Puttonen KA, Azevedo C, Lebedeva O, et al. Creation of a library of induced pluripotent stem cells from parkinsonian patients. Npj Park Dis. 2016;2(1):16009.","journal-title":"Npj Park Dis"},{"issue":"3","key":"592_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.stemcr.2019.01.005","volume":"12","author":"T Faal","year":"2019","unstructured":"Faal T, Phan DTT, Davtyan H, Scarfone VM, Varady E, Blurton-Jones M, et al. Induction of mesoderm and neural crest-derived pericytes from human pluripotent stem cells to study blood-brain barrier interactions. Stem Cell Rep. 2019;12(3):451\u201360.","journal-title":"Stem Cell Rep"},{"issue":"9","key":"592_CR18","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.celrep.2017.05.019","volume":"19","author":"A Kumar","year":"2017","unstructured":"Kumar A, D\u2019Souza SS, Moskvin OV, Toh H, Wang B, Zhang J, et al. Specification and diversification of Pericytes and smooth muscle cells from Mesenchymoangioblasts. Cell Rep. 2017;19(9):1902\u201316.","journal-title":"Cell Rep"},{"issue":"4","key":"592_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/stem.2577","volume":"35","author":"A Harding","year":"2017","unstructured":"Harding A, Cortez-Toledo E, Magner NL, Beegle JR, Coleal-Bergum DP, Hao D, et al. Highly efficient differentiation of endothelial cells from pluripotent stem cells requires the MAPK and the PI3K pathways. Stem Cells. 2017;35(4):909\u201319.","journal-title":"Stem Cells"},{"key":"592_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fncel.2019.00282","volume":"13","author":"LS Brown","year":"2019","unstructured":"Brown LS, Foster CG, Courtney JM, King NE, Howells DW, Sutherland BA. Pericytes and neurovascular function in the healthy and diseased brain. Front Cell Neurosci. 2019;13:282.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"592_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-024-03671-x","volume":"15","author":"NE King","year":"2024","unstructured":"King NE, Courtney JM, Brown LS, Fortune AJ, Blackburn NB, Fletcher JL, et al. Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility. Stem Cell Res Ther. 2024;15(1):59.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"592_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/intbio\/zyaa027","volume":"13","author":"LB Payne","year":"2021","unstructured":"Payne LB, Darden J, Suarez-Martinez AD, Zhao H, Hendricks A, Hartland C, et al. Pericyte migration and proliferation are tightly synchronized to endothelial cell sprouting dynamics. Integr Biol. 2021;13(2):31\u201343.","journal-title":"Integr Biol"},{"issue":"1","key":"592_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12935-022-02705-9","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Shojaei S. A review on the role of MEG8 lncRNA in human disorders. Cancer Cell Int. 2022;22(1):285.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"592_CR24","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10571-020-00904-4","volume":"41","author":"S Sui","year":"2021","unstructured":"Sui S, Sun L, Zhang W, Li J, Han J, Zheng J, et al. LncRNA MEG8 attenuates cerebral ischemia after ischemic stroke through targeting miR-130a-5p\/VEGFA signaling. Cell Mol Neurobiol. 2021;41(6):1311\u201324.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"592_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41598-022-04812-z","volume":"12","author":"V Kremer","year":"2022","unstructured":"Kremer V, Bink DI, Stanicek L, Van Ingen E, Gimbel T, Hilderink S, et al. MEG8 regulates tissue factor pathway inhibitor 2 (TFPI2) expression in the endothelium. Sci Rep. 2022;12(1):843.","journal-title":"Sci Rep"},{"issue":"1","key":"592_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbrc.2019.01.074","volume":"510","author":"B Zhang","year":"2019","unstructured":"Zhang B, Dong Y, Zhao Z. LncRNA MEG8 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting PPAR\u03b1. Biochem Biophys Res Commun. 2019;510(1):171\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"592_CR27","doi-asserted-by":"publisher","first-page":"697273","DOI":"10.3389\/fmolb.2021.697273","volume":"8","author":"D Xu","year":"2021","unstructured":"Xu D, Dai R, Chi H, Ge W, Rong J. Long non-coding RNA MEG8 suppresses Hypoxia-Induced Excessive Proliferation, Migration and inflammation of vascular smooth muscle cells by regulation of the miR-195-5p\/RECK Axis. Front Mol Biosci. 2021;8:697273.","journal-title":"Front Mol Biosci"},{"key":"592_CR28","doi-asserted-by":"publisher","first-page":"532891","DOI":"10.3389\/fneur.2020.532891","volume":"11","author":"Y Quan","year":"2020","unstructured":"Quan Y, Wang J, Wang S, Zhao J. Association of the plasma long non-coding RNA MEG3 with Parkinson\u2019s Disease. Front Neurol. 2020;11:532891.","journal-title":"Front Neurol"},{"issue":"8","key":"592_CR29","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s11011-021-00835-z","volume":"36","author":"H Huang","year":"2021","unstructured":"Huang H, Zheng S, Lu M. Downregulation of lncRNA MEG3 is involved in Parkinson\u2019s disease. Metab Brain Dis. 2021;36(8):2323\u20138.","journal-title":"Metab Brain Dis"},{"key":"592_CR30","doi-asserted-by":"publisher","first-page":"763323","DOI":"10.3389\/fimmu.2021.763323","volume":"12","author":"K Honarmand Tamizkar","year":"2021","unstructured":"Honarmand Tamizkar K, Gorji P, Gholipour M, Hussen BM, Mazdeh M, Eslami S, et al. Parkinson\u2019s disease is Associated with Dysregulation of circulatory levels of lncRNAs. Front Immunol. 2021;12:763323.","journal-title":"Front Immunol"},{"issue":"11","key":"592_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson Disease: a systematic review and Meta-analysis. JAMA Neurol. 2016;73(11):1316.","journal-title":"JAMA Neurol"},{"key":"592_CR32","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Y, Cao Z, Liu Q, Cheng Y. Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s Disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and Meta-analysis. Front Immunol. 2018;9:2122.","journal-title":"Front Immunol"},{"issue":"1","key":"592_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12974-016-0503-0","volume":"13","author":"J Rustenhoven","year":"2016","unstructured":"Rustenhoven J, Aalderink M, Scotter EL, Oldfield RL, Bergin PS, Mee EW, et al. TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function. J Neuroinflammation. 2016;13(1):37.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"592_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12974-019-1482-8","volume":"16","author":"C Perner","year":"2019","unstructured":"Perner C, Perner F, Gaur N, Zimmermann S, Witte OW, Heidel FH, et al. Plasma VCAM1 levels correlate with disease severity in Parkinson\u2019s disease. J Neuroinflammation. 2019;16(1):94.","journal-title":"J Neuroinflammation"},{"key":"592_CR35","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schr\u00f6der","year":"2018","unstructured":"Schr\u00f6der JB, Pawlowski M, Meyer Zu H\u00f6rste G, Gross CC, Wiendl H, Meuth SG, et al. Immune Cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s Disease. Front Neurol. 2018;9:1081.","journal-title":"Front Neurol"},{"issue":"1","key":"592_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-020-00124-z","volume":"6","author":"A Santaella","year":"2020","unstructured":"Santaella A, Kuiperij HB, Van Rumund A, Esselink RAJ, Van Gool AJ, Bloem BR, et al. Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson\u2019s disease. Npj Park Dis. 2020;6(1):21.","journal-title":"Npj Park Dis"},{"issue":"1","key":"592_CR37","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","volume":"10","author":"TM Sonninen","year":"2020","unstructured":"Sonninen TM, H\u00e4m\u00e4l\u00e4inen RH, Koskuvi M, Oksanen M, Shakirzyanova A, Wojciechowski S, et al. Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci Rep. 2020;10(1):14474.","journal-title":"Sci Rep"},{"issue":"1","key":"592_CR38","doi-asserted-by":"publisher","first-page":"22118","DOI":"10.1038\/s41598-023-49294-9","volume":"13","author":"S Ohtonen","year":"2023","unstructured":"Ohtonen S, Giudice L, J\u00e4ntti H, Fazaludeen MF, Shakirzyanova A, G\u00f3mez-Budia M, et al. Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson\u2019s disease related transcriptional profile and function. Sci Rep. 2023;13(1):22118.","journal-title":"Sci Rep"},{"issue":"11","key":"592_CR39","doi-asserted-by":"publisher","first-page":"108130","DOI":"10.1016\/j.isci.2023.108130","volume":"26","author":"KJ He","year":"2023","unstructured":"He KJ, Zhang JB, Liu JY, Zhao FL, Yao XY, Tang YT, et al. LRRK2 G2019S promotes astrocytic inflammation induced by oligomeric \u03b1-synuclein through NF-\u03baB pathway. iScience. 2023;26(11):108130.","journal-title":"iScience"},{"key":"592_CR40","doi-asserted-by":"publisher","first-page":"853372","DOI":"10.3389\/fnagi.2022.853372","volume":"14","author":"G Paul","year":"2022","unstructured":"Paul G, Elabi OF. Microvascular changes in Parkinson\u2019s Disease- Focus on the neurovascular unit. Front Aging Neurosci. 2022;14:853372.","journal-title":"Front Aging Neurosci"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-024-00592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-024-00592-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-024-00592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T19:02:48Z","timestamp":1731870168000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-024-00592-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1186\/s12987-024-00592-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5104876\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The use of the patient-derived material has been approved by the Hospital District of Northern Savo, research Ethics committee (#42\/\/2010 and #123\/\/2016).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"92"}}